Clinical outcomes, local-regional control and the role for metastasis-directed therapies in stage III non-small cell lung cancers treated with chemoradiation and durvalumab

BACKGROUND AND PURPOSE: Concurrent chemoradiation (cCRT) and durvalumab is standard therapy for patients with unresectable stage III non-small-cell lung cancers (NSCLC). Data is limited on outcomes with this regimen outside of clinical trials. Local-regional control rates remain undefined. MATERIALS...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Radiother Oncol
Hauptverfasser: Offin, Michael, Shaverdian, Narek, Rimner, Andreas, Lobaugh, Stephanie, Shepherd, Annemarie F., Simone, Charles B., Gelblum, Daphna Y., Wu, Abraham J., Lee, Nancy, Kris, Mark G., Rudin, Charles M., Zhang, Zhigang, Hellmann, Matthew D., Chaft, Jamie E., Gomez, Daniel R.
Format: Artigo
Sprache:Inglês
Veröffentlicht: 2020
Schlagworte:
Article
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC8239428/
https://ncbi.nlm.nih.gov/pubmed/32361014
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.radonc.2020.04.047
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge